Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Drug Approval Trends Don't Extend to CMOs

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.
Jun 2, 2013

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.

Strategic Partnering for Manufacturing

Eisai and Biogen Idec pursue an innovative approach to capacity management.
May 3, 2013

Eisai and Biogen Idec pursue an innovative approach to capacity management.

Strategic Partnering for Manufacturing

Eisai and Biogen Idec pursue an innovative approach to capacity management.
Apr 2, 2013

Eisai and Biogen Idec pursue an innovative approach to capacity management.

End of the Dedicated CMO?

Is the contract-only CMO an endangered species?
Mar 6, 2013

Is the contract-only CMO an endangered species?

End of the Dedicated CMO?

Is the contract-only CMO an endangered species?
Feb 2, 2013

Is the contract-only CMO an endangered species?

The State of Outsourcing Partnerships

Preferred-provider relationships are transforming the bio/pharmaceutical industry.
Feb 1, 2013

Preferred-provider relationships are transforming the bio/pharmaceutical industry.

Acquisitions Reshape the Bio/Pharm Services Industry

The quest to build critical mass and broaden capabilities has been a key factor in dealmaking.
Jan 9, 2013

The quest to build critical mass and broaden capabilities has been a key factor in dealmaking.

Acquisitions Reshape the Bio/Pharm Services Industry

The quest to build critical mass and broaden capabilities has been a key factor in deal-making.
Dec 2, 2012

The quest to build critical mass and broaden capabilities has been a key factor in deal-making.

Sizing the Market For Contract Manufacturing

Measuring the size of the market for contract manufacturing services requires a careful hand.
Nov 7, 2012

Measuring the size of the market for contract manufacturing services requires a careful hand.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here